The novel therapy of this peptide represents a significant advance in the handling of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide186358.ivasdesign.com/63182053/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment